Literature DB >> 316631

Treatment of bleeding oesophageal varices with somatostatin.

L Thulin, G Tydén, H Samnegård, O Muhrbeck, S Efendić.   

Abstract

Cyclic somatostatin was administered intravenously on eight occasions to five consecutive patients with massive haemalemesis due to oesophageal varices. The doses administered with 0--250 micrograms as bolus, followed by 100--250 micrograms per hr during 2--12 hrs. The source of bleeding was determined by endoscopy. The volume of bleeding was estimated from the clinical condition of the patient and by gastric irrigation and iced water. The bleeding stopped immediately on all occasions when somatostatin was administered. It is suggested that the effect is due to the ability of somatostatin to reduce regional splanchnic blood flows and portal pressure.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 316631

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  7 in total

Review 1.  Somatostatin in portal hypertension.

Authors:  J S Morgan; R J Groszmann
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

Review 2.  Recent advances in pancreatic hormone research.

Authors:  R G Long
Journal:  Postgrad Med J       Date:  1983-05       Impact factor: 2.401

3.  Nonsurgical management of emergency hemorrhage from esophageal varices.

Authors:  E R Schiff
Journal:  World J Surg       Date:  1984-10       Impact factor: 3.352

4.  Pharmacologic influence on esophageal varices: a preliminary report.

Authors:  A Lunderquist; A Alwmark; P Gullstrand; M Hall-Angeras; B Joelsson; T Owman; K I Pettersson; K G Tranberg
Journal:  Cardiovasc Intervent Radiol       Date:  1983       Impact factor: 2.740

5.  Somatostatin reduces gastric mucosal blood flow in normal subjects but not in patients with cirrhosis of the liver.

Authors:  A Sonnenberg; C West
Journal:  Gut       Date:  1983-02       Impact factor: 23.059

6.  Somatostatin does not reduce oesophageal variceal pressure in liver cirrhotics.

Authors:  G Kleber; T Sauerbruch; G Fischer; G Paumgartner
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

7.  Hemodynamic effects of somatostatin in the rat: relationship with plasma glucagon levels.

Authors:  J M Romeo; C Novo; A Fernández-Cruz; J M Lòpez-Novoa
Journal:  Heart Vessels       Date:  1990       Impact factor: 2.037

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.